The table below shows Dianthus Therapeutics, Inc. /DE/'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$2.04M
$6.24M
$2.83M
-
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$145.64M
$83.11M
$32.84M
$29.38M
$12.61M
$50.62M
SG&A
$34.33M
DNTH annual revenue (10-K history)
Dianthus Therapeutics, Inc. /DE/ reported annual revenue of $2.04M for fiscal year 2025. That is down 67.3% from $6.24M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.